Furthermore, it was stated that several chemotherapeutic drugs can enhance HDAC class I expression; for example, doxorubicin and cytarabine induce HDAC3 expression in leukemia cells (K562 and THP-1), contributing to acquired resistance as HDAC3 is critical for DNA damage control [26,27,28]. This evidence concerns the gene HDAC3 and leukemia.